Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Scand Cardiovasc J. 2023 Dec;57(1):17-24. doi: 10.1080/14017431.2022.2150787.
The present study aimed to compare safety and long-term prognosis of patients with chronic total coronary occlusions (CTO) stratified for remaining CTOs after percutaneous coronary intervention (PCI).
The study cohort consisted of patients with coronary artery disease who underwent CTO PCI in a high volume tertiary center from 2009 to 2019 and were registered in Danish high-quality registers. Patients with successful PCI of all CTOs were compared to patients with ≥1 remaining CTO post-procedural. Primary endpoints were analysed using Cox-regression and Kaplan-Meier estimates, and included all-cause mortality, major adverse cardio- and cerebrovascular events (MACCE) and a 30-day safety endpoint.
Procedural success rate was 87.7%, and 76.5% of patients had all CTO(s) opened post-PCI. Safety endpoint occurred in 4.6% of patients, and more frequently in patients with remaining CTO(s) (RD 4.9, 95%CI 0.1, 9.8). All-cause mortality was higher in patients with remaining CTO(s) (Unadjusted HR 1.65, 95% CI 1.03, 2.47, = .015. Adjusted HR 1.32, 95%CI 0.88-1.99, = .18) after eight years of follow-up. Risk of MACCE was significantly higher in patients with remaining CTO(s) (Unadjusted HR 1.79, 95% CI 1.34-2.41, < .001. Adjusted HR 1.51, 95% CI 1.11-2.05, = .009).
In our centre, CTO PCI was associated with high success rate and low risk of 30-days complications. Presence of remaining CTO(s) after final revascularization attempt was associated with higher but statistically insignificant long-term mortality but was an independent predictor of MACCE.
本研究旨在比较经皮冠状动脉介入治疗(PCI)后存在慢性完全闭塞(CTO)患者的安全性和长期预后。
研究队列包括 2009 年至 2019 年在一家高容量三级中心接受 CTO PCI 的冠心病患者,并在丹麦高质量登记处登记。成功 PCI 所有 CTO 的患者与术后存在≥1 个残余 CTO 的患者进行比较。主要终点采用 Cox 回归和 Kaplan-Meier 估计进行分析,包括全因死亡率、主要不良心脑血管事件(MACCE)和 30 天安全性终点。
手术成功率为 87.7%,76.5%的患者术后所有 CTO 均开放。安全性终点发生在 4.6%的患者中,在存在残余 CTO 的患者中更为常见(RD 4.9,95%CI 0.1,9.8)。在 8 年随访后,存在残余 CTO 的患者全因死亡率更高(未调整 HR 1.65,95%CI 1.03,2.47, = .015. 调整 HR 1.32,95%CI 0.88-1.99, = .18)。存在残余 CTO 的患者 MACCE 的风险显著更高(未调整 HR 1.79,95%CI 1.34-2.41, < .001. 调整 HR 1.51,95%CI 1.11-2.05, = .009)。
在我们的中心,CTO PCI 具有高成功率和低 30 天并发症风险。最终血运重建尝试后存在残余 CTO 与更高但无统计学意义的长期死亡率相关,但与 MACCE 独立相关。